The incidence of ventriculomegaly was found to be similar in both groups, with an occurrence of 0.8% (1 out of 121) in the EPO group and 0.8% (1 out of 130) in the No EPO group, resulting in a non-significant p-value of 0.959. The gene discussed is EPO; the disease is Ventriculomegaly.